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Background:  Endothelial dysfunction plays an important role in atherosclerosis initiation and plaque stability. Soluble thrombomodulin 
(sTM) has cytoprotective effects on vascular endothelium. We examined the role of autophagy in the beneficial effects of sTM on 
endothelial cells (ECs). 
methods and results:  Data were expressed as mean ± SE. Cultured human umbilical vein ECs were stressed with serum starvation 
(SS, 0.5% fetal bovine serum). EC autophagy was evaluated by immunofluorescence staining of microtubule-associated protein 1 light 
chain 3 (LC3) and monodansylcadaverine (MDC). Autophagy-related signaling proteins were evaluated with Western blot. SS significantly 
induced EC autophagy and sTM treatment suppressed starvation-induced EC autophagy (normal without SS vs. SS 24 hrs + saline vs. SS 
24 hrs + sTM 100 ng/mL, average LC3 puncta in 10 cells: 1.00 ± 0.65 vs. 22.65 ± 1.35 vs. 8.20 ± 0.20, p<0.01; average MDC staining in 
10 cells: 0.90 ± 1.37 vs. 17.80 ± 3.52 vs. 6.60 ± 2.17, p<0.01). Akt, mTOR and S6K phosphorylation was decreased while ATG5, LC3 and 
beclin-1 expression increased during starvation. However, sTM treatment restored Akt, mTOR and S6K phosphorylation during starvation 
and inhibited ATG5, LC3 and beclin-1 expression. EC proliferation was evaluated by BrdU assay and EC apoptosis was evaluated by Cell-
Death ELISA and flow cytometry. Treatment of sTM increased EC proliferation and decreased SS-induced EC apoptosis. Rapamycin, an 
autophagy inducer, decreased sTM-induced EC proliferation (normal vs. sTM 100 ng/mL vs. sTM 100 ng/mL + rapamycin 10 µg/mL vs. 
VEGF 100 ng/mL, BrdU ELISA absorbance: 1.28 ± 0.10 vs. 2.31 ± 0.16 vs. 0.58 ± 0.02 vs. 2.56 ± 0.05, p<0.05) and also abolished sTM 
effect on apoptosis (SS 24 hrs + saline vs. normal without SS vs. SS 24 hrs + sTM 100 ng/mL vs. SS 24 hrs + sTM 100 ng/mL + rapamycin 
10 µg/mL, Cell-Death ELISA, apoptosis ratio: 1 vs. 0.29 ± 0.03 vs. 0.39 ± 0.03 vs. 1.22 ± 0.13, p<0.01; flow cytometry, apoptotic cell 
percentage: 6.04 ± 1.01% vs. 1.50 ± 0.15% vs. 4.20 ± 0.67% vs. 7.37 ± 0.13%, p<0.05). 
Conclusion:  Autophagy modulation is an important molecular mechanism of sTM-mediated cytoprotective effects on vascular 
endothelium.
